Teva Canada announces availability of Aermony RespiClick, an innovative new device for the treatment of bronchial asthma
Teva Canada announces availability of Aermony RespiClick (fluticasone propionate inhalation powder), an innovative new device for the treatment of bronchial asthma. (Credit: Teva Pharmaceutical Industries Ltd.)